2948-1937

Health Nanotechnology

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 23 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact23 DOIs
2

Attach ORCID iDs across 19 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact19 DOIs

DOIs for this ISSN

Showing the top 5 of 28 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Optical imaging in biomedical research: guidelines and pract… (10.1186/s44301-025-00004-6)
Abstract ORCID
57.31 13
2 Natural lipid-based nanoformulations for enhancing hepatopro… (10.1186/s44301-025-00010-8)
Abstract ORCID
53.96 11
3 Unravelling the effects of silver nanoparticles on textiles:… (10.1186/s44301-025-00006-4)
Abstract ORCID
47.71 8
4 Nanotechnology in medicine: a double-edged sword for health… (10.1186/s44301-025-00008-2)
Abstract
40.58 41
5 Therapeutic potential of naïve and engineered milk extracell… (10.1186/s44301-025-00005-5)
Abstract ORCID
38.91 5
6 Beyond PEGylation: nanoparticle surface modulation for enhan… (10.1186/s44301-025-00014-4)
ORCID
38.60 34
7 Layered double hydroxides based nanomaterials: recent advanc… (10.1186/s44301-025-00017-1)
Abstract ORCID
34.95 4
8 Mitochondrial permeability transition pore (mPTP) as a targe… (10.1186/s44301-025-00019-z)
Abstract ORCID
34.95 4
9 The power of deoxyribonucleic acid and bio-robotics in creat… (10.1186/s44301-024-00002-0)
Abstract ORCID
30.10 3
10 AlphaFold 3 sheds insights into chemical enhancer-induced st… (10.1186/s44301-024-00003-z)
Abstract ORCID
30.10 3
11 Rethinking the need for ultra-high stretchability in stretch… (10.1186/s44301-025-00011-7)
Abstract ORCID
30.10 3
12 Customised extracellular vesicle therapeutics for neurologic… (10.1186/s44301-025-00007-3)
Abstract ORCID
23.86 2
13 Aptamer-conjugated liposome system for targeting MUC1-positi… (10.1186/s44301-024-00001-1)
Abstract
19.45 5
14 A three-step mitochondria-targeted photodynamic therapy plat… (10.1186/s44301-025-00009-1)
Abstract ORCID
15.05 1
15 DNA damage and oxidative stress induced by lambda-cyhalothri… (10.1186/s44301-025-00013-5)
Abstract ORCID
15.05 1
16 Bioreactor-enabled extracellular vesicle production for down… (10.1186/s44301-026-00021-z)
Abstract ORCID
15.05 1
17 Selecting nanocarrier platforms for drug delivery: a criteri… (10.1186/s44301-026-00026-8)
Abstract
15.05 3
18 Integrated implantable bioelectronic system based on intrins… (10.1186/s44301-025-00012-6)
ORCID
11.93 2
19 Advances in anthocyanin research: from extraction to functio… (10.1186/s44301-026-00023-x)
Abstract
11.93 2
20 Exosome-based cancer nanomedicine: a promising frontier in o… (10.1186/s44301-025-00015-3)
Abstract
0.00 0
21 Porous silicon nanoparticles for cancer bioimaging and thera… (10.1186/s44301-025-00016-2)
ORCID
0.00 0
22 Advancing probiotic delivery in cancer therapy: nanocarrier… (10.1186/s44301-025-00018-0)
0.00 4
23 Metallic- nanoparticles mediated programmed cell death in ca… (10.1186/s44301-026-00022-y)
Abstract
0.00 0
24 Gold nanoparticles for central nervous system drug delivery… (10.1186/s44301-026-00024-w)
ORCID
0.00 0
25 Antitumor potential of inorganic nanoparticles vs. bee venom… (10.1186/s44301-026-00028-6)
Abstract ORCID
0.00 0
26 Ligand-functionalized nanocarriers for targeted breast cance… (10.1186/s44301-026-00029-5)
Abstract
0.00 0
27 Nanoformulated phytochemicals for PCOS: therapeutic potentia… (10.1186/s44301-026-00030-y)
Abstract
0.00 0
28 Enrofloxacin-loaded Zein nanoparticles combat E. coli O157:H… (10.1186/s44301-026-00031-x)
Abstract ORCID
0.00 0